MENU
+Compare
ABEO
Stock ticker: NASDAQ
AS OF
Nov 20, 04:59 PM (EDT)
Price
$4.22
Change
+$0.02 (+0.48%)
Capitalization
228.96M

ABEO Abeona Therapeutics Forecast, Technical & Fundamental Analysis

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

ABEO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ABEO with price predictions
Nov 19, 2025

ABEO in -6.76% downward trend, sliding for three consecutive days on November 19, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ABEO declined for three days, in of 321 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ABEO as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for ABEO moved below the 200-day moving average on November 04, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

The Aroon Indicator for ABEO entered a downward trend on November 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ABEO's RSI Oscillator exited the oversold zone, of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for ABEO just turned positive on November 14, 2025. Looking at past instances where ABEO's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABEO advanced for three days, in of 251 cases, the price rose further within the following month. The odds of a continued upward trend are .

ABEO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.329) is normal, around the industry mean (27.606). P/E Ratio (3.475) is within average values for comparable stocks, (52.154). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.053). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (666.667) is also within normal values, averaging (329.190).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ABEO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABEO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ABEO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ABEO is expected to report earnings to fall 20.00% to -7 cents per share on March 23

Abeona Therapeutics ABEO Stock Earnings Reports
Q4'25
Est.
$-0.08
Q3'25
Beat
by $0.17
Q2'25
Beat
by $2.09
Q1'25
Beat
by $0.13
Q4'24
Beat
by $0.85
The last earnings report on November 12 showed earnings per share of -10 cents, beating the estimate of -27 cents. With 1.85M shares outstanding, the current market capitalization sits at 228.96M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
6555 Carnegie Avenue
Phone
+1 646 813-4701
Employees
84
Web
https://www.abeonatherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNVVY12.390.23
+1.91%
ConvaTec Group plc
FSUGY26.460.41
+1.58%
FORTESCUE LTD.
CNBB44.20N/A
N/A
CNB Community Bancorp Inc.
KPIFF0.03N/A
N/A
Edgewater Wireless Systems, Inc.
GCAAF47.71-0.03
-0.06%
Guardian Capital Group Ltd.

ABEO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABEO has been loosely correlated with OCUL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ABEO jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABEO
1D Price
Change %
ABEO100%
-6.14%
OCUL - ABEO
47%
Loosely correlated
+2.81%
IPSC - ABEO
45%
Loosely correlated
+4.82%
RGNX - ABEO
44%
Loosely correlated
-2.84%
AURA - ABEO
44%
Loosely correlated
-0.18%
NRIX - ABEO
43%
Loosely correlated
+13.09%
More